ABON PHARMACEUTICALS LLC has a total of 20 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are HIKMA PHARMACEUTICALS USA INC, HUNAN KANERGA PHARMACEUTICAL CO LTD and CMPD LICENSING LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Australia | 3 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Organic fine chemistry | |
#4 | Basic materials chemistry | |
#5 | Packaging and shipping |
# | Name | Total Patents |
---|---|---|
#1 | Zu Yanming | 20 |
#2 | Ahmed Salah U | 18 |
#3 | Chowdhury Tahseen A | 17 |
#4 | Muntazim Saad | 11 |
#5 | Neelam Karunakar | 10 |
#6 | Tian Shiying | 9 |
#7 | Lepree Jason | 7 |
#8 | Prajapti Hetalben | 5 |
#9 | Prajapati Hetalben | 3 |
#10 | Syed Mohammed Irfan | 2 |
Publication | Filing date | Title |
---|---|---|
WO2019241077A1 | Oral eliglustat transmucosal delivery system | |
WO2019094819A2 | Intravenous delivery systems for chemotherapy drugs | |
US2017196802A1 | Long Acting Injectable Formulations | |
AU2013344654B2 | Oral transmucosal drug delivery system | |
WO2011146611A1 | Modified gastroretentive drug delivery system for amine drugs |